Guidance to practitioners in conducting and reporting on an agreed-upon procedures engagement to assist management in evaluating the effectiveness of its corporate compliance program; Statement of position 99-1; by American Institute of Certified Public Accountants. Health Care Pilot Task Force
University of Mississippi
eGrove
Statements of Position American Institute of Certified Public Accountants(AICPA) Historical Collection
1999
Guidance to practitioners in conducting and
reporting on an agreed-upon procedures
engagement to assist management in evaluating the
effectiveness of its corporate compliance program;
Statement of position 99-1;
American Institute of Certified Public Accountants. Health Care Pilot Task Force
Follow this and additional works at: https://egrove.olemiss.edu/aicpa_sop
Part of the Accounting Commons, and the Taxation Commons
This Article is brought to you for free and open access by the American Institute of Certified Public Accountants (AICPA) Historical Collection at
eGrove. It has been accepted for inclusion in Statements of Position by an authorized administrator of eGrove. For more information, please contact
egrove@olemiss.edu.
Recommended Citation
American Institute of Certified Public Accountants. Health Care Pilot Task Force, "Guidance to practitioners in conducting and
reporting on an agreed-upon procedures engagement to assist management in evaluating the effectiveness of its corporate compliance
program; Statement of position 99-1;" (1999). Statements of Position. 237.
https://egrove.olemiss.edu/aicpa_sop/237
STATEMENT OF 
POSITION 99-1 
May 21, 1999 
Guidance to Practitioners in 
Conducting and Reporting on 
an Agreed-Upon Procedures 
Engagement to Assist 
Management in Evaluating the 
Effectiveness of Its Corporate 
Compliance Program 
Issued Under the Authority of the 
Auditing Standards Board 
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NOTE 
This Statement of Position presents the recommendations 
of the AICPA Health Care Pilot Task Force regarding the 
application of Statements on Standards for Attestation En-
gagements to agreed-upon procedures attestation engage-
ments performed to assist a health care provider in 
evaluating the effectiveness of its corporate compliance 
program consistent with the requirements of a Corporate 
Integrity Agreement entered into with the Office of Inspec-
tor General of the U.S. Department of Health and Human 
Services. The Auditing Standards Board has found the rec-
ommendations in this Statement of Position to be consis-
tent with existing standards covered by rule 202 of the 
AICPA Code of Professional Conduct. AICPA members 
should be prepared to justify departures from the recom-
mendations in this Statement of Position. 
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SUMMARY 
This Statement of Position provides guidance to practitioners 
in conducting and reporting on an agreed-upon procedures 
engagement performed pursuant to the AICPA Statements on 
Standards for Attestation Engagements to assist a health 
care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a 
Corporate Integrity Agreement (CIA) entered into with the 
Office of Inspector General (OIG) of the U.S. Department 
of Health and Human Services. CIAs are specific to the entity 
involved; consequently, users of this SOP should be familiar 
with the specific requirements of the entity's CIA. 
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Guidance to Practitioners in 
Conducting and Reporting on an 
Agreed-Upon Procedures Engagement 
to Assist Management in Evaluating 
the Effectiveness of Its Corporate 
Compliance Program 
Introduction and Background 
1. Within the past several years, the health care industry has 
experienced a significant increase in the number and mag-
nitude of allegations of fraud and abuse involving federal 
health care programs (for example, Medicare and Med-
icaid) and private health care insurance. These allegations 
have triggered regulatory scrutiny, litigation, significant 
monetary settlements, and negative publicity related to— 
among other things—coding and billing practices, patient 
referrals, cost reporting, quality of care, and clinical prac-
tices. Typically, as part of the global resolution of these 
allegations, the entity enters into a Corporate Integrity 
Agreement (CIA) with the Office of Inspector General 
(OIG) of the U.S. Department of Health and Human Ser-
vices. Such agreements require that management annu-
ally report on its compliance with the terms of the CIA 
and that there be an assessment of the entity's compliance 
with the CIA. This assessment includes a billing analysis, 
which may be performed by an independent review 
organization (such as a practitioner or consultant) or the 
provider (if permitted by the OIG), and an agreed-upon 
procedures engagement. 
2. This Statement of Position (SOP) provides guidance to 
practitioners in conducting and reporting on an agreed-
upon procedures engagement performed pursuant to the 
American Institute of Certified Public Accountants (AICPA) 
Statements on Standards for Attestation Engagements 
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(SSAEs) to assist an entity in evaluating the effectiveness 
of its corporate compliance program consistent with the 
requirements of a CIA.1 The terms of a CIA are unique to 
the entity; consequently, users of this SOP need to be famil-
iar with the actual CIA and its requirements. 
3. This SOP applies to agreed-upon procedures engagements 
to assist in evaluating an entity's compliance for a specified 
period. Such engagements should follow the AICPA attesta-
tion standards, including SSAE No. 1, Attestation Stan-
dards (AICPA, Professional Standard, vol. 1, AT sec. 100); 
SSAE No. 3, Compliance Attestation (AICPA, Professional 
Standards, vol. 1, AT sec. 500); and SSAE No. 4,Agreed-
Upon Procedures Engagements (AICPA, Professional 
Standards, vol. 1, AT sec. 600). The engagement should be 
conducted in accordance with standards established by the 
AICPA, including the criteria set forth in this SOP. However, 
this SOP is not intended to provide all the required criteria 
set forth in individual CIAs, nor all the applicable stan-
dards established by the AICPA. Additionally, the SOP con-
tains some guidance that may be applied in evaluating an 
organization's corporate compliance program, even though 
the program was not imposed by a CIA. 
Overview of a Typical Corporate 
Integrity Agreement 
4. A CIA is an agreement between a health care provider and 
the OIG in conjunction with a global settlement of a fraud 
investigation. Such an agreement typically seeks to establish 
a compliance program within the health care provider (for 
example, hospital, clinical lab, physician group) that will 
promote compliance with the requirements of Medicare, 
Medicaid, and all other federal health care programs. 
1. The practitioner also might be engaged to assist in other areas beyond an agreed-upon 
procedures engagement such as providing consulting services in connection with eval-
uating the company's billing practices, policies, and procedures as required by the CIA 
or in implementing, assessing, and reporting on voluntarily adopted compliance pro-
grams. In addition, the practitioner may assist in preparing an entity's self-disclosure 
reports to federal health agencies related to billing errors and other compliance matters. 
Similarly, practitioners may be involved in an entity's preparation of government-
required (but not CIA-imposed) compliance reporting (for example, contract require-
ments for Medicare part C) beyond an agreed-upon procedures engagement. 
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5. CIAs are case-specific. Their terms are tailored to address 
the organizational and operating deficiencies related to 
providing and billing for health care services that have 
been identified by the OIG, the entity, or others. Detailed 
compliance requirements are imposed as a condition for 
continued participation in federal health care programs. 
A sample CIA, provided by the OIG and intended to iden-
tify potential requirements, is included in appendix A, 
"Sample Corporate Integrity Agreement." Typical agree-
ments cover five years and require the entity to address 
the following areas: 
• Appointment of a compliance officer and establish-
ment of a compliance committee 
• Establishment of a code of conduct 
• Establishment of policies and procedures regarding 
the compliance program 
• Development of an information and education pro-
gram as to CIA requirements, compliance program and 
code of conduct 
• Annual assessment of billing policies, procedures, 
and practices 
• Establishment of a confidential disclosure program 
• Prohibition of employment of excluded or convicted 
persons 
• Notification to OIG of investigation or legal proceedings 
• Reporting of credible evidence of misconduct 
• Notifications to OIG of new provider locations 
• Provision of implementation and annual reports 
• Proper notification and submission of required 
reports 
• Granting of OIG access to documents and individuals 
to conduct assessments 
• Documentation of record retention requirements 
• Awareness of disclosure criteria 
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• Agreement to comply with certain default provisions, 
penalties, and remedies 
• Review of rights as to dispute resolution 
• Review of effective and binding agreement clauses 
Conditions for Engagement Performance 
6. A practitioner may perform an agreed-upon procedures en-
gagement related to management's compliance with a CIA if 
all of the conditions specified in AT sec. 600.10 of SSAE No. 
4 and AT sec. 500.09 through 500.11 of SSAE No. 3 are met. 
7. As discussed more fully in the SSAEs noted in paragraph 6, 
Management's assertions as to its compliance must be ca-
pable of evaluation against reasonable criteria that either 
have been established by a recognized body or are stated in 
or attached to the practitioner's report in a sufficiently 
clear and comprehensive manner. Generally, to avoid con-
fusion, management's assertions, which are based on the 
specific terms of its CIA, should be attached to the practi-
tioner's report. If the entity is not subject to a CIA, man-
agement may develop its assertions using the model CIA. A 
sample based on the model CIA, which is not meant to be 
all-inclusive, is included as appendix B, "Sample Statement 
of Management's Assertions." 
Establishing an Understanding With the Client 
8. The practitioner should document the understanding in the 
working papers, preferably through a written communication 
with the client, such as an engagement letter. Appendix G, 
"Sample Engagement Letter," contains a sample engagement 
letter that may be used for this kind of engagement. 
Users' Responsibilities 
9. Users typically would be the management of the health 
care provider and the OIG. Management is responsible for 
ensuring that the entity complies with the requirements of 
the CIA. That responsibility encompasses (a) identifying 
applicable compliance requirements, (b) establishing and 
maintaining internal control policies and procedures to 
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provide reasonable assurance that the entity complies with 
those requirements, (c) evaluating and monitoring the en-
tity's compliance, and (d) preparing reports that satisfy 
legal, regulatory, or contractual requirements. Manage-
ment's evaluation may include documentation such as ac-
counting or statistical data, policy manuals, accounting 
manuals, narrative memoranda, procedural write-ups, 
flowcharts, completed questionnaires, internal auditors' re-
ports, and other special studies or analyses. The form and 
extent of documentation will vary depending on the nature 
of the compliance requirements and the size and complex-
ity of the entity. Management may engage the practitioner 
to gather information to assist it in evaluating the entity's 
compliance. Regardless of the procedures performed by 
the practitioner, management must accept responsibility 
for its assertions and must not base such assertions solely 
on the practitioner's procedures. 
10. Specified users are responsible for the sufficiency (nature, 
timing, and extent) of the agreed-upon procedures because 
they best understand their own needs. The specified users as-
sume the risk that such procedures might be insufficient for 
their purposes. In addition, the specified users assume the 
risk that they might misunderstand or otherwise inappropri-
ately use findings properly reported by the practitioner. 
Practitioner's Responsibilities 
11. The objective of the practitioner's agreed-upon procedures 
is to present specific findings to assist users in evaluating 
an entity's compliance with the requirements specified in 
the CIA. (See appendix D, "Sample Procedures.") 
12. The practitioner's procedures generally may be as limited 
or extensive as the specified users desire, as long as the 
specified users agree upon the procedures performed or to 
be performed and take responsibility for the sufficiency of 
the agreed-upon procedures for their purposes. 
13. To satisfy the requirements that the practitioner and the 
specified users agree upon the procedures performed or to 
be performed and that the specified users take responsibil-
ity for the sufficiency of the agreed-upon procedures for 
their purposes, ordinarily the practitioner should commu-
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nicate directly with and obtain affirmative acknowledgment 
from each of the specified users. For the purposes of these 
engagements, an effective way to obtain this agreement 
ordinarily is to distribute a draft of the report, detailing the 
procedures, that is expected to be issued to the OIG with a 
request for any comments it may have. 
14. To avoid possible misunderstandings, the practitioner 
should circulate the draft with a legend stating that these 
are the procedures expected to be performed, and unless 
informed otherwise, the practitioner assumes that there 
are no additional procedures that he or she is expected to 
perform. A legend such as the following might be used. 
This draft is furnished solely for the purpose of indicat-
ing the form of report that we would expect to be able to 
furnish pursuant to the request by Management of 
[Provider] for our performance of limited procedures re-
lating to [Provider's] compliance with the Corporate In-
tegrity Agreement with the Office of Inspector General 
(OIG) of the U.S. Department of Heath and Human Ser-
vices. Based on our discussions with [Provider], it is our 
understanding that the procedures outlined in this draft 
report are those we are expected to follow. Unless in-
formed otherwise within ninety (90) days of this trans-
mittal, we shall assume that there are no additional 
procedures that we are expected to follow. The text of 
the definitive report will depend, of course, on the re-
sults of the procedures. 
Involvement of a Specialist2 
15. The practitioner's education and experience enable him or 
her to be knowledgeable about business matters in general, 
but he or she is not expected to have the expertise of a per-
son trained for or qualified to engage in the practice of an-
other profession or occupation. In certain circumstances, 
it may be appropriate to involve a specialist to assist the 
practitioner in the performance of one or more procedures. 
The following are examples. 
2. A specialist is a person (or firm) possessing special skill or knowledge in a particular 
field other than the attest function. As used herein, a specialist does not include a person 
employed by the practitioner's firm who participates in the attestation engagement. 
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• An attorney might provide assistance concerning the 
application of laws, regulations, or rules to a client's 
situation. 
• A medical specialist might provide assistance in un-
derstanding the characteristics of diagnosis codes 
documented in patient medical records. 
16. The practitioner and the specified users should agree to the 
involvement of a specialist in assisting a practitioner in the 
performance of an agreed-upon procedures engagement. 
This agreement may be reached when obtaining agreement 
on the procedures performed or to be performed and ac-
knowledgment of responsibility for the sufficiency of the 
procedures, as discussed previously. The practitioner's re-
port should describe the nature of the assistance provided 
by the specialist. 
17. A practitioner may agree to apply procedures to the report 
or work product of a specialist that does not constitute as-
sistance by the specialist to the practitioner in an agreed-
upon procedures engagement. For example, the practitioner 
may make reference to information contained in a report 
of a specialist in describing an agreed-upon procedure. 
However, it is inappropriate for the practitioner to agree to 
merely read the specialist's report solely to describe or re-
peat the findings, or to take responsibility for all or a portion 
of any procedures performed by a specialist or the special-
ist's work product. 
Internal Auditors and Other Personnel3 
18. The agreed-upon procedures to be enumerated or referred 
to in the practitioner's report are to be performed entirely 
by the practitioner except as discussed in paragraphs 16 
through 18 of this SOP. However, internal auditors or other 
personnel may prepare schedules, accumulate data, per-
form an internal assessment of management's compliance, 
or provide other information for the practitioner's use in 
performing the agreed-upon procedures. 
3. SAS No. 65, The Auditor's Consideration of the Internal Audit Function in an Audit of 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not 
apply to agreed-upon procedures engagements. 
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19. A practitioner may agree to perform procedures on infor-
mation documented in the working papers of internal audi-
tors. For example, the practitioner may agree to— 
• Repeat all or some of the procedures. 
• Determine whether the internal auditors' working 
papers contain documentation of procedures per-
formed and whether the findings documented in the 
working papers are presented in a report by the in-
ternal auditors. 
20. However, it is inappropriate for the practitioner to— 
• Agree to merely read the internal auditor's report 
solely to describe or repeat its findings. 
• Take responsibility for all or a portion of any proce-
dures performed by internal auditors by reporting 
those findings as the practitioner's own. 
• Report in any manner that implies shared responsi-
bility for the procedures with the internal auditors. 
Planning the Engagement 
21. Planning an agreed-upon procedures engagement involves 
working with the users to develop an overall strategy for the 
expected conduct and scope of the engagement. To develop 
such a strategy, practitioners should have adequate techni-
cal training and proficiency in the attestation standards and 
have adequate knowledge in health care regulatory matters 
to enable them to sufficiently understand the events, trans-
actions, and practices that, in their judgment, have a signifi-
cant effect on the presentation of the assertions. 
Working Papers 
22. The practitioner should prepare and maintain working pa-
pers in connection with an engagement under the attestation 
standards; such working papers should be appropriate to 
the circumstances and the practitioner's needs on the en-
gagement to which they apply. 
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23. Concern over access to the practitioner's working papers 
might cause some clients to inquire about working paper re-
quirements. In situations where the practitioner is requested 
to not maintain copies of certain client documentation, or to 
not prepare and maintain documentation similar to client 
documents, the practitioner may refer to the auditing Inter-
pretation, "Evidential Matter: Auditing Interpretation of Sec-
tion 326" (AICPA, Professional Standards, vol. 1, AU sec. 
9326.06-.17), for guidance. See the Attest Interpretation, 
"Attestation Standards: Attestation Engagements Interpreta-
tions of Section 100" (AICPA, Professional Standards, vol. 
1, AT sec. 9100.58), for guidance related to providing access 
to or photocopies of working papers to a regulator in con-
nection with work performed on an attestation engagement. 
Management's Representations 
24. The practitioner should obtain written representation from 
management on various matters including the following: 
a. Acknowledging management's responsibility for com-
plying with the CIA 
b. Acknowledging management's responsibility for estab-
lishing and maintaining effective internal control over 
compliance 
c. Stating that management has performed an evalua-
tion of the entity's compliance with CIA-specified 
requirements 
d. Stating management's assertions about the entity's 
compliance with all aspects of the CIA, including the 
specific issues that gave rise to the CIA4 
4. Depending on the circumstances, representations in the following areas might be 
appropriate. 
- Violations or possible violations of laws or regulations, such as those related to the 
Medicare and Medicaid antifraud and abuse statutes 
- Compliance of third-party billings with applicable coding guidelines (for example, 
IGD-9-CM, CPT) and laws and regulations (including medical necessity, proper ap-
provals, and proper rendering of care) 
- Proper filing of all required Medicare, Medicaid, and similar reports under the applic-
able reimbursement rules and regulations (including nature of costs—allowable, 
patient-related, properly allocated, in accordance with applicable rules and regula-
tions, properly adjusted to reflect prior audit adjustments) and adequacy of disclosures 
(including disputed costs) 
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e. Stating that management has disclosed to the practi-
tioner all known noncompliance with the CIA 
f. Stating that management has made available all doc-
umentation relating to compliance with the CIA 
g. Stating management's interpretation of any compli-
ance requirements that have varying interpretations 
h. Stating that management has disclosed any communi-
cation from regulatory agencies, internal auditors, 
legal counsel, and other parties concerning matters 
regarding the design, implementation, and monitoring 
of the policies and procedures in place, including 
communication received between the end of the 
reporting period and the date of the practitioner's 
report (the date of signature) 
i. Stating that management has disclosed any known 
noncompliance occurring subsequent to the end of 
the reporting period 
j. Describing any related material fraud or abuse, other 
fraud, abuse or illegal acts that, whether or not mate-
rial, involve management or other employees who 
have a significant role in the entity's design, imple-
mentation, and monitoring of the policies and proce-
dures in place upon which compliance is based 
k. Stating that management has disclosed to the practition-
ers, orally or in writing, information about past noncom-
pliance issues covered in the settlement agreement that 
gave rise to the CIA and the related corrective measures 
taken to support compliance in those areas 
Management's refusal to furnish all appropriate written 
representations constitutes a limitation on the scope of 
the engagement sufficient to require withdrawal from the 
engagement. 
Reporting Considerations 
25. A practitioner should present the results of applying 
agreed-upon procedures to the specific subject matter in 
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the form of findings. The practitioner should not provide 
negative assurance about whether the assertion is fairly 
stated in accordance with established or stated criteria. 
For example, the practitioner should not include a state-
ment that "nothing came to my attention that caused me 
to believe that the assertion is not fairly stated in accor-
dance with (established or stated) criteria." 
26. The practitioner should report all findings from the applica-
tion of the agreed-upon procedures. The concept of material-
ity does not apply to findings to be reported in an agreed-upon 
procedures engagement unless the definition of materiality is 
agreed to by the specified users. Any agreed-upon materiality 
limits should be described in the practitioner's report. 
27. The practitioner has no obligation to perform procedures 
beyond the agreed-upon procedures. However, if noncom-
pliance related to management's assertion comes to the 
practitioner's attention by other means, such information 
ordinarily should be included in his or her report. 
28. The practitioner may become aware of noncompliance re-
lated to management's assertion that occurs subsequent to 
the reporting period but before the date of the practi-
tioner's report. The practitioner should consider including 
information regarding such noncompliance in his or her re-
port. However, the practitioner has no responsibility to 
perform procedures to detect such noncompliance other 
than obtaining management's representation about non-
compliance in the subsequent period. 
29. The practitioner should follow the reporting guidance in 
AT sec. 600.33 through 600.38 of SSAE 4. A sample report 
is included in appendix E, "Sample Report." 
30. Evaluating compliance with certain requirements may re-
quire interpretation of the laws, regulations, rules, contracts, 
or other agreements that establish those requirements. In 
such situations, the practitioner should consider whether 
he or she is provided with the reasonable criteria required 
to evaluate an assertion under the third general attestation 
standard. If these interpretations are significant, the prac-
titioner may include a paragraph stating the description 
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and the source of interpretations made by the entity's man-
agement. An example of such a paragraph, which should 
precede the procedures and findings paragraph(s), follows: 
We have been informed that, under [name of entity's] inter-
pretation of [identify the compliance requirement], [ex-
plain the nature and source of the relevant interpretation]. 
The date of completion of the agreed-upon procedures 
should be used as the date of the practitioner's report. 
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APPENDIX A 
Sample Corporate Integrity Agreement 
Corporate Integrity Agreement 
Between the Office of Inspector General 
of the Department of Health and 
Human Services and [Provider] 
I. Preamble 
[Provider] ("[Provider]") hereby enters into this Corporate 
Integrity Agreement ("CIA") with the Office of Inspector Gen-
eral ("OIG") of the United States Department of Health and 
Human Services ("HHS") to ensure compliance by its employ-
ees with the requirements of Medicare, Medicaid and all other 
Federal health care programs (as defined in 42 U.S.C. 1320a-
7b(f)) (hereinafter collectively referred to as the "Federal 
health care programs"). [Provider's] compliance with the 
terms and conditions in this CIA shall constitute an element 
of [Provider's] present responsibility with regard to participa-
tion in the Federal health care programs. Contemporaneously 
with this CIA, [Provider] is entering into a Settlement Agree-
ment with the United States, and this CIA is incorporated by 
reference into the Settlement Agreement. 
II. Term of the CIA 
The period of the compliance obligations assumed by 
[Provider] under this CIA shall be 5 years from the effective 
date of this CIA (unless otherwise specified). The effective 
date of this CIA will be the date on which the final signatory 
of this CIA executes this CIA (the "effective date"). 
Source: Office of the Inspector General of the United States Department of Health and 
Human Services. 
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Corporate Integrity Obligations 
[Provider] shall establish a compliance program that in-
cludes the following elements. 
A. Compliance Officer. 
Within ninety (90) days after the effective date of this CIA, 
[Provider] shall appoint an individual to serve as Compli-
ance Officer, who shall be responsible for developing and 
implementing policies, procedures, and practices designed 
to ensure compliance with the requirements set forth in 
this CIA and with the requirements of the Federal health 
care programs. The Compliance Officer shall be a member 
of senior management of [Provider], shall make regular (at 
least quarterly) reports regarding compliance matters di-
rectly to the CEO and/or to the Board of Directors of 
[Provider] and shall be authorized to report to the Board of 
Directors at any time. The Compliance Officer shall be re-
sponsible for monitoring the day-to-day activities engaged 
in by [Provider] to further its compliance objectives as 
well as any reporting obligations created under this CIA. In 
the event a new Compliance Officer is appointed during 
the term of this CIA, [Provider] shall notify the OIG, in 
writing, within fifteen (15) days of such a change. 
[Provider] shall also appoint a Compliance Committee 
within ninety (90) days after the effective date of this CIA. 
The Compliance Committee shall, at a minimum, include the 
Compliance Officer and any other appropriate officers as 
necessary to meet the requirements of this CIA within the 
provider's corporate structure (e.g., senior executives of each 
major department, such as billing, clinical, human resources, 
audit, and operations). The Compliance Officer shall chair 
the Compliance Committee and the Committee shall support 
the Compliance Officer in fulfilling his/her responsibilities. 
B. Written Standards. 
1. Code of Conduct Within ninety (90) days of the effec-
tive date of this CIA, [Provider] shall establish a Code of 
Conduct. The Code of Conduct shall be distributed to all em-
ployees within ninety (90) days of the effective date of this 
CIA. [Provider] shall make the promotion of, and adherence 
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to, the Code of Conduct an element in evaluating the per-
formance of managers, supervisors, and all other employ-
ees. The Code of Conduct shall, at a minimum, set forth: 
a. [Provider's] commitment to full compliance with all 
statutes, regulations, and guidelines applicable to 
Federal health care programs, including its commit-
ment to prepare and submit accurate billings consis-
tent with Federal health care program regulations 
and procedures or instructions otherwise communi-
cated by the Health Care Financing Administration 
("HCFA") (or other appropriate regulatory agencies) 
and/or its agents; 
b. [Provider's] requirement that all of its employees 
shall be expected to comply with all statutes, regula-
tions, and guidelines applicable to Federal health care 
programs and with [Provider's] own policies and pro-
cedures (including the requirements of this CIA); 
c. the requirement that all of [Provider's] employees 
shall be expected to report suspected violations of 
any statute, regulation, or guideline applicable to 
Federal health care programs or with [Provider's] 
own policies and procedures; 
d. the possible consequences to both [Provider] and to 
any employee of failure to comply with all statutes, 
regulations, and guidelines applicable to Federal 
health care programs and with [Provider's] own poli-
cies and procedures or of failure to report such non-
compliance; and 
e. the right of all employees to use the confidential dis-
closure program, as well as [Provider's] commitment 
to confidentiality and non-retaliation with respect to 
disclosures. 
Within ninety (90) days of the effective date of the CIA, 
each employee shall certify, in writing, that he or she has 
received, read, understands, and will abide by [Provider's] 
Code of Conduct. New employees shall receive the Code of 
Conduct and shall complete the required certification 
within two (2) weeks after the commencement of their em-
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ployment or within ninety (90) days of the effective date of 
the CIA, whichever is later. 
[Provider] will annually review the Code of Conduct and 
will make any necessary revisions. These revisions shall be 
distributed within thirty (30) days of initiating such a 
change. Employees shall certify on an annual basis that 
they have received, read, understand and will abide by the 
Code of Conduct. 
2. Policies and Procedures. Within ninety (90) days of the 
effective date of this CIA, [Provider] shall develop and ini-
tiate implementation of written Policies and Procedures re-
garding the operation of [Provider's] compliance program 
and its compliance with all federal and state health care 
statutes, regulations, and guidelines, including the require-
ments of the Federal health care programs. At a minimum, 
the Policies and Procedures shall specifically address [in-
sert language relevant to allegations in the case]. In addi-
tion, the Policies and Procedures shall include disciplinary 
guidelines and methods for employees to make disclosures 
or otherwise report on compliance issues to [Provider] 
management through the Confidential Disclosure Program 
required by section III.E. [Provider] shall assess and up-
date as necessary the Policies and Procedures at least an-
nually and more frequently, as appropriate. A summary of 
the Policies and Procedures will be provided to OIG in the 
Implementation Report. The Policies and Procedures will 
be available to OIG upon request. 
Within ninety (90) days of the effective date of the CIA, the 
relevant portions of the Policies and Procedures shall be 
distributed to all appropriate employees. Compliance staff 
or supervisors should be available to explain any and all 
policies and procedures. 
C. Training and Education. 
1. General Training. Within ninety (90) days of the effec-
tive date of this CIA, [Provider] shall provide at least two 
(2) hours of training to each employee. This general train-
ing shall explain [Provider's]: 
a. Corporate Integrity Agreement requirements; 
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b. Compliance Program (including the Policies and 
Procedures as they pertain to general compliance 
issues); and 
c. Code of Conduct. 
These training material shall be made available to the OIG, 
upon request. 
New employees shall receive the general training described 
above within thirty (30) days of the beginning of their em-
ployment or within ninety (90) days after the effective date 
of this CIA, whichever is later. Each year, every employee 
shall receive such general training on an annual basis. 
2. Specific Training. Within ninety (90) days of the effec-
tive date of this CIA, each employee who is involved di-
rectly or indirectly in the delivery of patient care and/or in 
the preparation or submission of claims for reimbursement 
for such care (including, but not limited to, coding and 
billing) for any Federal health care programs shall receive 
at least [insert number of training hours] hours of training 
in addition to the general training required above. This 
training shall include a discussion of: 
a. the submission of accurate bills for services rendered 
to Medicare and/or Medicaid patients; 
b. policies, procedures and other requirements applica-
ble to the documentation of medical records; 
c. the personal obligation of each individual involved 
in the billing process to ensure that such billings are 
accurate; 
d. applicable reimbursement rules and statutes; 
e. the legal sanctions for improper billings; and 
f. examples of proper and improper billing practices. 
These training materials shall be made available to OIG, 
upon request. Persons providing the training must be 
knowledgeable about the subject area. 
Affected new employees shall receive this training within 
thirty (30) days of the beginning of their employment or 
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whichever is later. If a new employee has any responsibility 
for the delivery of patient care, the preparation or submis-
sion of claims and/or the assignment of procedure codes 
prior to completing this specific training, a [Provider] em-
ployee who has completed the substantive training shall 
review all of the untrained person's work regarding the 
assignment of billing codes. 
Each year, every employee shall receive such specific 
training on an annual basis. 
3. Certification. Each employee shall certify, in writing, 
that he or she has attended the required training. The cer-
tification shall specify the type of training received and the 
date received. The Compliance Officer shall retain the cer-
tifications, along with specific course materials. These shall 
be made available to OIG upon request. 
D. Review Procedures. 
[Provider] shall retain an entity, such as an accounting, au-
diting or consulting firm (hereinafter "Independent Review 
Organization"), to perform review procedures to assist 
[Provider] in assessing the adequacy of its billing and com-
pliance practices pursuant to this CIA. This shall be an an-
nual requirement and shall cover a twelve (12) month 
period. The Independent Review Organization must have 
expertise in the billing, coding, reporting and other require-
ments of the Federal health care programs from which 
[Provider] seeks reimbursement. The Independent Review 
Organization must be retained to conduct the assessment of 
the first year within ninety (90) days of the effective date of 
this CIA. For purposes of complying with this review proce-
dures requirement, the OIG at its discretion, may permit 
the [Provider] to utilize internal auditors to perform the re-
view(s). In such case, the [Provider] will engage the Inde-
pendent Review Organization to verify the propriety of the 
internal auditors' methods and accuracy of their results. 
The [Provider] will request the Independent Review Orga-
nization to produce a report on its findings which report 
shall be included in the Annual Report to the OIG. 
The Independent Review Organization (or the [Provider], if 
permitted by the OIG, as set forth above) will conduct two 
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separate engagements. One will be an analysis of [Provider's] 
billing to the Federal health care programs to assist the 
[Provider] and OIG in determining compliance with all 
applicable statutes, regulations, and directives/guidance 
("billing engagement"). The second engagement will assist 
the [Provider] and OIG in determining whether [Provider] 
is in compliance with this CIA ("compliance engagement"). 
1. Billing Engagement The billing engagement shall consist 
of a review of a statistically valid sample of claims for the 
relevant period. The sample size shall be determined 
through the use of a probe sample1. At a minimum, the full 
sample must be within a ninety (90) percent confidence 
level and a precision of twenty-five (25) percent. The probe 
sample must contain at least thirty (30) sample units and 
cannot be used as part of the full sample. Both the 
probe sample and the sample must be selected through 
random numbers. [Provider] shall use OIG's Office of 
Audit Services Statistical Sampling Software, also known 
as "RAT-STATS", which is available through the Internet at 
www.hhs.gov/progorg/ratstat. html. 
Each annual billing engagement analysis shall include the 
following components in its methodology: 
a. Billing Engagement Objective: Provide a statement 
stating clearly the objective intended to be achieved 
by the billing engagement and the procedure or com-
bination of procedures that will be applied to achieve 
the objective. 
b. Billing Engagement Population: Identify the popu-
lation, which is the group about which information 
is needed. Explain the methodology used to de-
velop the population and provide the basis for this 
determination. 
c. Sources of Data: Provide a full description of the source 
of the information upon which the billing engagement 
conclusions will be based, including the legal or other 
standards applied, documents relied upon, payment 
data, and/or any contractual obligations. 
1. Probe sample is defined as a small, random preliminary sample. 
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d. Sampling Unit: Define the sampling unit, which is 
any of the designated elements that comprise the 
population of interest. 
e. Sampling Frame: Identify the sampling frame, which 
is the totality of the sampling units from which the 
sample will be selected. 
As part of the billing engagement: 
a. Inquire of management as to the procedures and con-
trols affecting the billing process subject to the annual 
assessment as specified in the CIA. Document that as-
pect of the billing process (e.g., flow of documents, 
processing activities), and those controls that will be 
tested in the sample. The documentation may consist 
of flow charts, excerpts from policies and procedures 
manuals, control questionnaires, etc. 
b. Report the sample results, including the overall error 
rate and the nature of the errors found (e.g., no doc-
umentation, inadequate documentation, assignment 
of incorrect code). 
c. Document findings related to [Provider's] proce-
dures to correct inaccurate billings and codings to 
the Federal health care programs and findings re-
garding the steps [Provider] is taking to bring its 
operations into compliance or to correct problems 
identified by the audit. 
2. Agreed-upon Procedures or Compliance Engagement 
An Independent Review Organization (or the [Provider], if 
permitted by the OIG) shall also conduct an agreed-upon 
procedures or compliance engagement, which shall assist 
the users in determining whether [Provider's] program, 
policies, procedures, and operations comply with the terms 
of this CIA. This engagement shall include a section by sec-
tion analysis of the requirements of this CIA. 
A complete copy of the Independent Review Organization's 
billing and agreed-upon procedures or compliance engage-
ment shall be included in each of [Provider's] Annual Re-
ports to OIG. 
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3. Disclosure of Overpayments and Material Deficiencies. 
If, as a result of these engagements, [Provider] or the Inde-
pendent Review Organization identifies any billing, coding 
or other policies, procedures and/or practices that result in 
an overpayment, [Provider] shall notify the payor (e.g., 
Medicare fiscal intermediary or carrier) within 30 days of 
discovering the deficiency or overpayment and take reme-
dial steps within 60 days of discovery (or such additional 
time as may be agreed to by the payor) to correct the prob-
lem, including preventing the deficiency from recurring. 
The notice to the payor shall include: 
a. a statement that the refund is being made pursuant 
to this CIA; 
b. a description of the complete circumstances sur-
rounding the overpayment; 
c. the methodology by which the overpayment was de-
termined; 
d. the amount of the overpayment; 
e. any claim-specific information used to determine the 
over-payment (e.g., beneficiary health insurance num-
ber, claim number, service date, and payment date); 
f. the cost reporting period; and 
g. the provider identification number under which the 
repayment is being made. 
If [Provider] determines an overpayment represents a mate-
rial deficiency, contemporaneous with [Provider's] notifica-
tion to the payor as provided above, [Provider] shall also 
notify OIG of. 
a. a complete description of the material deficiency; 
b. amount of overpayment due to the material defi-
ciency; 
c. [Provider's] action(s) to correct and prevent such ma-
terial deficiency from recurring; 
d. the payor's name, address, and contact person where 
the overpayment was sent; 
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e. the date of the check and identification number (or 
electronic transaction number) on which the over-
payment was repaid. 
For purposes of this CIA, an "overpayment" shall mean the 
amount of money the provider has received in excess of 
the amount due and payable under the Federal health care 
programs' statutes, regulations or program directives, in-
cluding carrier and intermediary instructions. 
For purposes of this CIA, a "material deficiency" shall 
mean anything that involves: (i) a substantial overpayment 
or improper payment relating to the Medicare and/or Med-
icaid programs; (ii) conduct or policies that clearly violate 
the Medicare and/or Medicaid statute, regulations or direc-
tives issued by HCFA and/or its agents; or (iii) serious qual-
ity of care implications for federal health care beneficiaries 
or recipients. A material deficiency may be the result of an 
isolated event or a series of occurrences. 
4. Verification/Validation. In the event that the OIG deter-
mines that it is necessary to conduct an independent review 
to determine whether or the extent to which [Provider] is 
complying with its obligations under this CIA, [Provider] 
agrees to pay for the reasonable cost of any such review or 
engagement by the OIG or any of its designated agents. 
E. Confidential Disclosure Program. 
Within ninety (90) days after the effective date of this CIA, 
[Provider] shall establish a Confidential Disclosure Program, 
which must include measures (e.g., a toll-free compliance 
telephone line) to enable employees, contractors, agents or 
other individuals to disclose, to the Compliance Officer or 
some other person who is not in the reporting individual's 
chain of command, any identified issues or questions associ-
ated with [Provider's] policies, practices or procedures with 
respect to the Federal health care program, believed by the 
individual to be inappropriate. [Provider] shall publicize the 
existence of the hotline (e.g., e-mail to employees or post 
hotline number in prominent common areas). 
The Confidential Disclosure Program shall emphasize a 
non-retribution, non-retaliation policy, and shall include a 
reporting mechanism for anonymous, confidential commu-
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nication. Upon receipt of a complaint, the Compliance Offi-
cer (or designee) shall gather the information in such a way 
as to elicit all relevant information from the individual re-
porting the alleged misconduct. The Compliance Officer (or 
designee) shall make a preliminary good faith inquiry into 
the allegations set forth in every disclosure to ensure that 
he or she has obtained all of the information necessary to 
determine whether a further review should be conducted. 
For any disclosure that is sufficiently specific so that it rea-
sonably: (1) permits a determination of the appropriateness 
of the alleged improper practice, and (2) provides an oppor-
tunity for taking corrective action, [Provider] shall conduct 
an internal review of the allegations set forth in such a dis-
closure and ensure that proper follow-up is conducted. 
The Compliance Officer shall maintain a confidential dis-
closure log, which shall include a record and summary of 
each allegation received, the status of the respective inves-
tigations, and any corrective action taken in response to 
the investigation. 
F. Ineligible Persons. 
[Provider] shall not hire or engage as contractors any "In-
eligible Person." For purposes of this CIA, an "Ineligible 
Person" shall be any individual or entity who: (i) is cur-
rently excluded, suspended, debarred or otherwise ineligi-
ble to participate in the Federal health care programs; or 
(ii) has been convicted of a criminal offense related to the 
provision of health care items or services and has not been 
reinstated in the Federal health care programs after a pe-
riod of exclusion, suspension, debarment, or ineligibility. 
Within ninety (90) days of the effective date of this CIA, 
[Provider] will review its list of current employees and con-
tractors against the General Services Administration's List 
of Parties Excluded from Federal Programs (available 
through the Internet at http://www.arnet.gov/epls) and the 
HHS/OIG Cumulative Sanction Report (available through 
the Internet at http://www.dhhs.gov/progorg/oig) to ensure 
that it is not currently employing or contracting with any 
Ineligible Person. Thereafter, [Provider] will review the list 
once semi-annually to ensure that no current employees or 
contractors are or have become Ineligible Persons. 
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To prevent hiring or contracting with any Ineligible Person, 
[Provider] shall screen all prospective employees and 
prospective contractors prior to engaging their services by 
(i) requiring applicants to disclose whether they are Ineligi-
ble Persons, and (ii) reviewing the General Services Admin-
istration's List of Parties Excluded from Federal Programs 
(available through the Internet at http://www.arnet.gov/epls) 
and the HHS/OIG Cumulative Sanction Report (available 
through the Internet at http://www.dhhs.gov/progorg/oig). 
If [Provider] has notice that an employee or agent is charged 
with a criminal offense related to any Federal health care 
program, or is suspended or proposed for exclusion during 
his or her employment or contract with [Provider], within 
10 days of receiving such notice [Provider] will remove 
such employee from responsibility for, or involvement 
with, [Provider's] business operations related to the Federal 
health care programs until the resolution of such criminal 
action, suspension, or proposed exclusion. If [Provider] has 
notice that an employee or agent has become an Ineligible 
Person, [Provider] will remove such person from responsi-
bility for, or involvement with, [Provider's] business opera-
tions related to the Federal health care programs and shall 
remove such person from any position for which the per-
son's salary or the items or services rendered, ordered, or 
prescribed by the person are paid in whole or in part, di-
rectly or indirectly, by Federal health care programs or 
otherwise with Federal funds at least until such time as the 
person is reinstated into participation in the Federal health 
care programs. 
G. Notification of Proceedings. 
Within thirty (30) days of discovery, [Provider] shall notify 
OIG, in writing, of any ongoing investigation or legal pro-
ceeding conducted or brought by a governmental entity or 
its agents involving an allegation that [Provider] has com-
mitted a crime or has engaged in fraudulent activities or any 
other knowing misconduct. This notification shall include a 
description of the allegation, the identity of the investigat-
ing or prosecuting agency, and the status of such investiga-
tion or legal proceeding. [Provider] shall also provide 
written notice to OIG within thirty (30) days of the resolu-
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tion of the matter, and shall provide OIG with a description 
of the findings and/or results of the proceedings, if any. 
H. Reporting. 
1. Credible evidence of misconduct. If [Provider ] discovers 
credible evidence of misconduct from any source and, after 
reasonable inquiry, has reason to believe that the miscon-
duct may violate criminal, civil, or administrative law con-
cerning [Provider's] practices relating to the Federal 
health care programs, then [Provider] shall promptly re-
port the probable violation of law to OIG. Defendants shall 
make this disclosure as soon as practicable, but, not later 
than thirty (30) days after becoming aware of the existence 
of the probable violation. The [Provider's] report to OIG 
shall include: 
a. the findings concerning the probable violation, includ-
ing the nature and extent of the probable violation; 
b. [Provider's] actions to correct such probable viola-
tion; and 
c. any further steps it plans to take to address such prob-
able violation and prevent it from recurring. 
To the extent the misconduct involves an overpayment, 
the report shall include the information listed in section 
III.D.3 regarding material deficiencies. 
2. Inappropriate Billing. If [Provider] discovers inappro-
priate or incorrect billing through means other than the In-
dependent Review Organization's engagement, the provider 
shall follow procedures in section III.D.3 regarding over-
payments and material deficiencies. 
IV. New Locations 
In the event that [Provider] purchases or establishes new 
business units after the effective date of this CIA, [Provider] 
shall notify OIG of this fact within thirty (30) days of the date 
of purchase or establishment. This notification shall include 
the location of the new operation(s), phone number, fax 
number, Federal health care program provider number(s) (if 
any), and the corresponding payor(s) (contractor specific) 
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that has issued each provider number. All employees at 
such locations shall be subject to the requirements in this 
CIA that apply to new employees (e.g., completing certifi-
cations and undergoing training). 
V. Implementation and Annual Reports 
A. Implementation Report. 
Within one hundred and twenty (120) days after the effec-
tive date of this CIA, [Provider] shall submit a written re-
port to OIG summarizing the status of its implementation 
of the requirements of this CIA. This Implementation Re-
port shall include: 
1. the name, address, phone number and position de-
scription of the Compliance Officer required by sec-
tion III.A; 
2. the names and positions of the members of the Com-
pliance Committee required by section III.A; 
3. a copy of [Provider's] Code of Conduct required by 
section III.B.1; 
4. the summary of the Policies and Procedures required 
by section III.B.2; 
5. a description of the training programs required by 
section III.C including a description of the targeted 
audiences and a schedule of when the training ses-
sions were held; 
6. a certification by the Compliance Officer that: 
a. the Policies and Procedures required by section III.B 
have been developed, are being implemented, and 
have been distributed to all pertinent employees ; 
b. all employees have completed the Code of Con-
duct certification required by section III.B.1; and 
c. all employees have completed the training and ex-
ecuted the certification required by section III.C. 
7. a description of the confidential disclosure program 
required by section III.E; 
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8. the identity of the Independent Review Organiza-
tion(s) and the proposed start and completion date 
of the first audit; and 
9. a summary of personnel actions taken pursuant to 
section III.F. 
B. Annual Reports. 
[Provider] shall submit to OIG an Annual Report with re-
spect to the status and findings of [Provider's] compliance 
activities. The Annual Reports shall include: 
1. any change in the identity or position description of 
the Compliance Officer and/or members of the Com-
pliance Committee described in section III .A; 
2. a certification by the Compliance Officer that: 
a. all employees have completed the annual Code of 
Conduct certification required by section III.B.1; 
and 
b. all employees have completed the training and ex-
ecuted the certification required by section III.C. 
3. notification of any changes or amendments to the 
Policies and Procedures required by section III.B and 
the reasons for such changes (e.g., change in con-
tractor policy); 
4. a complete copy of the report prepared pursuant to 
the Independent Review Organization's billing and 
compliance engagement, including a copy of the 
methodology used. 
5. [Provider's] response/corrective action plan to any is-
sues raised by the Independent Review Organization. 
6. a summary of material deficiencies reported through-
out the course of the previous twelve (12) months 
pursuant to III.D.3 and III.H. 
7. a report of the aggregate overpayments that have 
been returned to the Federal health care programs 
that were discovered as a direct or indirect result of 
implementing this CIA. Overpayment amounts should 
be broken down into the following categories: Medicare, 
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Medicaid (report each applicable state separately) 
and other Federal health care programs; 
8. a copy of the confidential disclosure log required by 
section III.E; 
9. a description of any personnel action (other than 
hiring) taken by [Provider] as a result of the obliga-
tions in section III.F; 
10. a summary describing any ongoing investigation or 
legal proceeding conducted or brought by a govern-
ment entity involving an allegation that [Provider] 
has committed a crime or has engaged in fraudulent 
activities, which have been reported pursuant to sec-
tion III.G. The statement shall include a description 
of the allegation, the identity of the investigating or 
prosecuting agency, and the status of such investiga-
tion, legal proceeding or requests for information; 
11. a corrective action plan to address the probable vio-
lations of law identified in section III.H; and 
12. a listing of all of the [Provider's] locations (including 
locations and mailing addresses), the corresponding 
name under which each location is doing business, the 
corresponding phone numbers and fax numbers, each 
location's Federal health care program provider identi-
fication number(s) and the payor (specific contractor) 
that issued each provider identification number. 
The first Annual Report shall be received by the OIG no 
later than one year and thirty (30) days after the effective 
date of this CIA. Subsequent Annual Reports shall be sub-
mitted no later than the anniversary date of the due date of 
the first Annual Report. 
C. Certifications. 
The Implementation Report and Annual Reports shall in-
clude a certification by the Compliance Officer under 
penalty of perjury, that: (1) [Provider] is in compliance with 
all of the requirements of this CIA, to the best of his or her 
knowledge; and (2) the Compliance Officer has reviewed the 
Report and has made reasonable inquiry regarding its con-34 
tent and believes that, upon such inquiry, the information is 
accurate and truthful. 
VI. Notifications and Submission 
of Reports 
Unless otherwise stated in writing subsequent to the effective 
date of this CIA, all notifications and reports required under 
this CIA shall be submitted to the entities listed below: 
OIG: 
Civil Recoveries Branch—Compliance Unit 
Office of Counsel to the Inspector General 
Office of Inspector General 
U.S. Department of Health and Human Services 
Cohen Building, Room 5527 
330 Independence Avenue, SW 
Washington, DC 20201 
Phone 202-619-2078; Fax 202-205-0604 
[Provider]: 
[Address and Telephone number of Provider's 
Compliance Contact] 
VII. OIG Inspection, Audit and 
Review Rights 
In addition to any other rights OIG may have by statute, reg-
ulation, or contract, OIG or its duly authorized representa-
tive(s), may examine [Provider's] books, records, and other 
documents and supporting materials for the purpose of veri-
fying and evaluating: (a) [Provider's] compliance with the 
terms of this CIA; and (b) [Provider's] compliance with the 
requirements of the Federal health care programs in which it 
participates. The documentation described above shall be 
made available by [Provider] to OIG or its duly authorized 
representative(s) at all reasonable times for inspection, audit 
or reproduction. Furthermore, for purposes of this provision, 
OIG or its duly authorized representative(s) may interview 
any of [Provider's] employees who consent to be inter-
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viewed at the employee's place of business during normal 
business hours or at such other place and time as may be 
mutually agreed upon between the employee and OIG. 
[Provider] agrees to assist OIG in contacting and arranging 
interviews with such employees upon OIG's request. 
[Provider's] employees may elect to be interviewed with or 
without a representative of [Provider] present. 
VIII. Document and Record Retention 
[Provider] shall maintain for inspection all documents and 
records relating to reimbursement from the Federal health 
care programs or to compliance with this CIA one year 
longer than the term of this CIA (or longer if otherwise re-
quired by law). 
IX. Disclosures 
Subject to HHS's Freedom of Information Act ("FOIA") pro-
cedures, set forth in 45 C.F.R. Part 5, the OIG shall make a 
reasonable effort to notify [Provider] prior to any release by 
OIG of information submitted by [Provider] pursuant to its 
obligations under this CIA and identified upon submission 
by [Provider] as trade secrets, commercial or financial infor-
mation and privileged and confidential under the FOIA 
rules. [Provider] shall refrain from identifying any informa-
tion as trade secrets, commercial or financial information 
and privileged and confidential that does not meet the crite-
ria for exemption from disclosure under FOIA. 
X. Breach and Default Provisions 
[Provider] is expected to fully and timely comply with all 
of the obligations herein throughout the term of this CIA or 
other time frames herein agreed to. 
A. Stipulated Penalties for Failure to Comply with Certain 
Obligations. 
As a contractual remedy, [Provider] and OIG hereby agree 
that failure to comply with certain obligations set forth in 
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this CIA may lead to the imposition of the following monetary 
penalties (hereinafter referred to as "Stipulated Penalties") in 
accordance with the following provisions. 
1. A Stipulated Penalty of $2,500 (which shall begin to 
accrue on the day after the date the obligation be-
came due) for each day, beginning 120 days after the 
effective date of this CIA and concluding at the end of 
the term of this CIA, [Provider] fails to have in place 
any of the following: 
a. a Compliance Officer, 
b. a Compliance Committee; 
c. a written Code of Conduct; 
d. written Policies and Procedures; 
e. a training program; and 
f. a Confidential Disclosure Program; 
2. A Stipulated Penalty of $2,500 (which shall begin to 
accrue on the day after the date the obligation became 
due) for each day [Provider] fails to meet any of the 
deadlines to submit the Implementation Report or the 
Annual Reports to the OIG. 
3. A Stipulated Penalty of $2,000 (which shall begin to 
accrue on the date the failure to comply began) for 
each day [Provider]: 
a. hires or contracts with an Ineligible Person after 
that person has been listed by a federal agency as 
excluded, debarred, suspended or otherwise ineli-
gible for participation in the Medicare, Medicaid 
or any other Federal health care program (as de-
fined in 42 U.S.C. 1320a7b(f)). This Stipulated 
Penalty shall not be demanded for any time period 
if [Provider] can demonstrate that it did not dis-
cover the person's exclusion or other ineligibility 
after making a reasonable inquiry (as described in 
section III.F) as to the status of the person. 
b. employs or contracts with an Ineligible Person and 
that person: (i) has responsibility for, or involve-
ment with, [Provider's] business operations re-
lated to the Federal health care programs or (ii) is 
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in a position for which the person's salary or the 
items or services rendered, ordered, or prescribed 
by the person are paid in whole or in part, directly 
or indirectly, by the Federal health care programs 
or otherwise with Federal funds (this Stipulated 
Penalty shall not be demanded for any time period 
during which [Provider] can demonstrate that it 
did not discover the person's exclusion or other 
ineligibility after making a reasonable inquiry (as 
described in III.F) as to the status of the person); 
c. employs or contracts with a person who: (i) has 
been charged with a criminal offense related to any 
Federal health care program, or (ii) is suspended 
or proposed for exclusion, and that person has re-
sponsibility for, or involvement with, [Provider's] 
business operations related to the Federal health 
care programs (this Stipulated Penalty shall not be 
demanded for any time period before 10 days after 
[Provider] received notice of the relevant matter 
or after the resolution of the matter). 
4. A Stipulated Penalty of $1,500 (which shall begin to 
accrue on the date the [Provider] fails to grant access) 
for each day [Provider] fails to grant access to the in-
formation or documentation as required in section V 
of this CIA. 
5. A Stipulated Penalty of $1,000 (which shall begin to 
accrue ten (10) days after the date that OIG provides 
notice to [Provider] of the failure to comply) for each 
day [Provider] fails to comply fully and adequately 
with any obligation of this CIA. In its notice to 
[Provider], the OIG shall state the specific grounds for 
its determination that the [Provider] has failed to 
comply fully and adequately with the CIA obliga-
tion(s) at issue. 
B. Payment of Stipulated Penalties. 
1. Demand Letter. Upon a finding that [Provider] has failed 
to comply with any of the obligations described in section 
X.A and determining that Stipulated Penalties are appropri-
ate, OIG shall notify [Provider] by personal service or certi-
fied mail of (a) [Provider's] failure to comply; and (b) the 
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OIG's exercise of its contractual right to demand payment 
of the Stipulated Penalties (this notification is hereinafter 
referred to as the "Demand Letter"). 
Within fifteen (15) days of the date of the Demand Letter, 
[Provider] shall either (a) cure the breach to the OIG's sat-
isfaction and pay the applicable stipulated penalties, or (b) 
request a hearing before an HHS administrative law judge 
("ALJ") to dispute the OIG's determination of noncompli-
ance, pursuant to the agreed-upon provisions set forth below 
in section X.D. In the event [Provider] elects to request an 
ALJ hearing, the Stipulated Penalties shall continue to ac-
crue until [Provider] cures, to the OIG's satisfaction, the al-
leged breach in dispute. Failure to respond to the Demand 
Letter in one of these two manners within the allowed time 
period shall be considered a material breach of this CIA 
and shall be grounds for exclusion under section X.C. 
2. Timely Written Requests for Extensions. [Provider] may 
submit a timely written request for an extension of time to 
perform any act or file any notification or report required 
by this CIA. Notwithstanding any other provision in this 
section, if OIG grants the timely written request with re-
spect to an act, notification, or report, Stipulated Penalties 
for failure to perform the act or file the notification or re-
port shall not begin to accrue until one day after [Provider] 
fails to meet the revised deadline as agreed to by the OIG-
approved extension. Notwithstanding any other provision 
in this section, if OIG denies such a timely written request, 
Stipulated Penalties for failure to perform the act or file the 
notification or report shall not begin to accrue until two (2) 
business days after [Provider] receives OIG's written denial 
of such request. A "timely written request" is defined as a 
request in writing received by OIG at least five (5) business 
days prior to the date by which any act is due to be per-
formed or any notification or report is due to be filed. 
3. Form of Payment. Payment of the Stipulated Penalties 
shall be made by certified or cashier's check, payable to "Sec-
retary of the Department of Health and Human Services," 
and submitted to OIG at the address set forth in section VI. 
4. Independence from Material Breach Determination. Ex-
cept as otherwise noted, these provisions for payment of 
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Stipulated Penalties shall not affect or otherwise set a stan-
dard for the OIG's determination that [Provider] has mate-
rially breached this CIA, which decision shall be made at 
the OIG's discretion and governed by the provisions in sec-
tion X.C, below. 
C. Exclusion for Material Breach of this CIA. 
1. Notice of Material Breach and Intent to Exclude. The par-
ties agree that a material breach of this CIA by [Provider] 
constitutes an independent basis for [Provider's] exclusion 
from participation in the Federal health care programs (as 
defined in 42 U.S.C. 1320a7b(f)). Upon a determination by 
OIG that [Provider] has materially breached this CIA and 
that exclusion should be imposed, the OIG shall notify 
[Provider] by certified mail of (a) [Provider's] material 
breach; and (b) OIG's intent to exercise its contractual right 
to impose exclusion (this notification is hereinafter referred 
to as the "Notice of Material Breach and Intent to Exclude"). 
2. Opportunity to Cure. [Provider] shall have thirty-five 
(35) days from the date of the Notice of Material Breach 
and Intent to Exclude Letter to demonstrate to the OIG's 
satisfaction that: 
a. [Provider] is in full compliance with this CIA; 
b. the alleged material breach has been cured; or 
c. the alleged material breach cannot be cured within 
the 35-day period, but that: (i) [Provider] has begun 
to take action to cure the material breach, (ii) 
[Provider] is pursuing such action with due diligence, 
and (iii) [Provider] has provided to OIG a reasonable 
timetable for curing the material breach. 
3. Exclusion Letter. If at the conclusion of the thirty-five 
(35) day period, [Provider] fails to satisfy the requirements 
of section X.C.2, OIG may exclude [Provider] from partici-
pation in the Federal health care programs. OIG will notify 
[Provider] in writing of its determination to exclude 
[Provider] (this letter shall be referred to hereinafter as 
the "Exclusion Letter"). Subject to the Dispute Resolution 
provisions in section X.D, below, the exclusion shall go into 
effect thirty (30) days after the date of the Exclusion Letter. 
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The exclusion shall have national effect and will also apply 
to all other federal procurement and non-procurement pro-
grams. If [Provider] is excluded under the provisions of 
this CIA, [Provider] may seek reinstatement pursuant to 
the provisions at 42 C.F.R. §§1001.3001-.3004. 
4. Material Breach. A material breach of this CIA means: 
a. a failure by [Provider] to report a material deficiency, 
take corrective action and pay the appropriate re-
funds, as provided in section III.D; 
b. repeated or flagrant violations of the obligations under 
this CIA, including, but not limited to, the obligations 
addressed in section X.A of this CIA; 
c. a failure to respond to a Demand Letter concerning 
the payment of Stipulated Penalties in accordance 
with section X.B above; or 
d. a failure to retain and use an Independent Review 
Organization for review purposes in accordance with 
section III.D. 
D. Dispute Resolution. 
1. Review Rights. Upon the OIG's delivery to [Provider] 
of its Demand Letter or of its Exclusion Letter, and as an 
agreed-upon contractual remedy for the resolution of dis-
putes arising under the obligation of this CIA, [Provider] 
shall be afforded certain review rights comparable to the 
ones that are provided in 42 U.S.C. §§1320a7(f) and 42 
C.F.R. §1005 as if they applied to the Stipulated Penalties 
or exclusion sought pursuant to this CIA. Specifically, the 
OIG's determination to demand payment of Stipulated 
Penalties or to seek exclusion shall be subject to review 
by an ALJ and, in the event of an appeal, the Depart-
mental Appeals Board ("DAB"), in a manner consistent 
with the provisions in 42 C.F.R. §§1005.2-1005.2 1. 
Notwithstanding the language in 42 C.F.R. §1005.2(c), the 
request for a hearing involving stipulated penalties shall 
be made within fifteen (15) days of the date of the Demand 
Letter and the request for a hearing involving exclusion 
shall be made within thirty (30) days of the date of the 
Exclusion Letter. 
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2. Stipulated Penalties Review. Notwithstanding any provi-
sion of Title 42 of the United States Code or Chapter 42 of 
the Code of Federal Regulations, the only issues in a pro-
ceeding for stipulated penalties under this CIA shall be (a) 
whether [Provider] was in full and timely compliance with 
the obligations of this CIA for which the OIG demands pay-
ment; and (b) the period of noncompliance. [Provider] 
shall have the burden of proving its full and timely compli-
ance and the steps taken to cure the noncompliance, if 
any. If the ALJ finds for the OIG with regard to a finding of 
a breach of this CIA and orders [Provider] to pay Stipu-
lated Penalties, such Stipulated Penalties shall become due 
and payable twenty (20) days after the ALJ issues such a 
decision notwithstanding that [Provider] may request re-
view of the ALJ decision by the DAB. 
3. Exclusion Review. Notwithstanding any provision of 
Title 42 of the United States Code or Chapter 42 of the 
Code of Federal Regulations, the only issues in a proceed-
ing for exclusion based on a material breach of this CIA 
shall be (a) whether [Provider] was in material breach of 
this CIA; (b) whether such breach was continuing on the 
date of the Exclusion Letter; and (c) the alleged material 
breach cannot be cured within the 35-day period, but that 
(i) [Provider] has begun to take action to cure the material 
breach, (ii) [Provider] is pursuing such action with due 
diligence, and (iii) [Provider] has provided to OIG a rea-
sonable timetable for curing the material breach. 
For purposes of the exclusion herein, exclusion shall take 
effect only after an ALJ decision that is favorable to the 
OIG. [Provider's] election of its contractual right to appeal 
to the DAB shall not abrogate the OIG's authority to ex-
clude [Provider] upon the issuance of the ALJ's decision. If 
the ALJ sustains the determination of the OIG and deter-
mines that exclusion is authorized, such exclusion shall 
take effect twenty (20) days after the ALJ issues such a de-
cision, notwithstanding that [Provider] may request review 
of the ALJ decision by the DAB. 
4. Finality of Decision. The review by an ALJ or DAB pro-
vided for above shall not be considered to be an appeal right 
arising under any statutes or regulations. Consequently, the 
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parties to this CIA agree that the DAB's decision (or the 
ALJ's decision if not appealed) shall be considered final for 
all purposes under this CIA and [Provider] agrees to waive 
any right it may have to appeal the decision administra-
tively, judicially or otherwise seek review by any court or 
other adjudicative forum. 
XI. Effective and Binding Agreement 
Consistent with the provisions in the Settlement Agreement 
pursuant to which this CIA is entered, and into which this 
CIA is incorporated, [Provider] and OIG agree as follows: 
A. This CIA shall be binding on the successors, assigns 
and transferees of [Provider]; 
B. This CIA shall become final and binding on the date 
the final signature is obtained on the CIA; 
C. Any modifications to this CIA shall be made with the 
prior written consent of the parties to this CIA; and 
D. The undersigned [Provider] signatories represent 
and warrant that they are authorized to execute this 
CIA. The undersigned OIG signatory represents that 
he is signing this CIA in his official capacity and that 
he is authorized to execute this CIA. 
ON BEHALF OF [PROVIDER] 
DATE 
DATE 
DATE 
[Please identify all signatories] 
ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL 
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 
LEWIS MORIS DATE 
Assistant Inspector General for Legal Affairs 
Office of Inspector General 
U.S. Department of Health and Human Services 
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APPENDIX B 
Sample Statement of 
Management's Assertions 
[Date] 
In connection with the Corporate Integrity Agreement (CIA) 
entered into with the Office of the Inspector General of the 
United States Department of Health and Human Services 
dated [date], we make the following assertions, which are 
true to the best of our knowledge and belief. 
Governance 
Within 90 days of the date of the CIA, we— 
1. Established a Compliance Committee, which meets 
at least monthly and requires a quorum to meet. 
2. Appointed to our Compliance Committee members 
who include at a minimum those individuals speci-
fied in the CIA. 
3. Delegated to the Compliance Committee the author-
ity to implement and monitor the CIA, as evidenced 
by the organization chart or the Compliance Com-
mittee's charter. 
4. Appointed a compliance officer, who reports directly 
to the individual specified in the CIA. 
We appointed a compliance officer who— 
1. Has sufficient staff and resources to carry out his or 
her responsibilities. 
2. Actively participates in compliance training. 
3. Has authority to conduct full and complete internal 
investigations without restriction. 
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4. Periodically revises the compliance program to meet 
changing circumstances and risks. 
Billing Practices, Policies, and Procedures 
Although no system of internal controls can provide ab-
solute assurance that all bills comply in all respects with 
Medicare, Medicaid, and other federal health care program 
guidelines, we are not aware of any material weaknesses in 
our billing practices, policies, and procedures. Billings to 
third-party payors comply in all material respects with 
applicable coding principles and laws and regulations (in-
cluding those dealing with Medicare and Medicaid antifraud 
and abuse) and only reflect charges for goods and services 
that were medically necessary, properly approved by regu-
latory bodies (e.g., the Food and Drug Administration), if 
required and properly rendered. [Insert other assertions as 
necessary to address matters covered in the CIA.] Any 
Medicare, Medicaid, and other federal health program 
billing deficiencies that we identified have been properly 
reported to the applicable payor within 60 days of discov-
ery of the deficiency. 
Corporate Integrity Policy 
1. Our policy was developed and implemented within 
[number] days of execution of the CIA. 
2. The policy addresses the Company's commitment to 
preparation and submission of accurate billings con-
sistent with the standards set forth in federal health 
care program statutes, regulations, procedures and 
guidelines or as otherwise communicated by Health 
Care Financing Administration (HCFA), its agents or 
any other agency engaged in the administration of the 
applicable federal health care program. 
3. The policy addressed the specific issues that gave rise 
to the settlement, as well as other risk areas identi-
fied by the OIG in published Fraud Alerts issued 
through [date]. 
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4. Further details on the development and implementa-
tion of our policy were provided to the OIG in our letter 
dated [date]. 
5. Our policy was distributed to all employees, physi-
cians and independent contractors involved in sub-
mitting or preparing requests for reimbursement. 
6. We have prominently displayed a copy of our policy 
on the Company's premises. 
Information and Education Program 
As discussed more fully in our letter to the OIG dated [date], 
we conducted an Information and Education Program within 
[number] days of the CIA. The Information and Education 
Program requires that each officer, employee, agent and 
contractor charged with administering federal health care 
programs (including, but not limited to billers, coders, 
nurses, physicians, medical records, hospital administra-
tion and other individuals directly involved in billing fed-
eral health care programs) receive at least [number] hours 
of training. 
The training provided to employees involved in billing, cod-
ing, and/or charge capture consisted of instructions on sub-
mitting accurate bills, the personal obligations of each 
individual to ensure billings are accurate, the nature of 
company-imposed disciplinary actions on individuals who 
violate company policies and/or laws and regulations, applic-
able federal health care program rules, legal sanctions 
against the company for submission of false or fraudulent in-
formation, and how to report potential abuses or fraud. The 
training material addresses those issues underlying our set-
tlement with the OIG. 
The experience of the trainers is consistent with the topics 
presented. 
Confidential Disclosure Program 
Our Confidential Disclosure Program— 
1. Was established within [number] days of the CIA. 
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2. Enables any employee to disclose any practices or 
billing procedures relating to federal health care 
programs. 
3. Provides a toll-free telephone line maintained by the 
Company, which Company representatives have indi-
cated is maintained twenty-four hours a day, seven 
days a week, for the purpose of making any disclosures 
regarding compliance with the Company's Compliance 
Program, the obligations in the CIA, and Company's 
overall compliance with federal and state standards. 
4. Includes policies requiring the review of any disclo-
sures to permit a determination of the appropriate-
ness of the billing practice alleged to be involved and 
any corrective action to be taken to ensure that 
proper follow-up is conducted. 
5. A detailed summary of the communications (includ-
ing the number of disclosures by employees and the 
dates of such disclosures) concerning billing practices 
reported as, and found to be, inappropriate under the 
Confidential Disclosure Program, and the results of 
any internal review and the follow-up on such dis-
closures are summarized in Attachment [title] to our 
Annual Report. 
Excluded Individuals or Entities 
Company policy— 
1. Prohibits the employment of or contracting with an 
individual or entity that is listed by a federal agency 
as convicted of abuse or excluded, suspended or other-
wise ineligible for participation in federal health care 
programs. 
2. Includes a process to make an inquiry into the status 
of any potential employee or independent contractor. 
3. Provides for an annual review of the status of all ex-
isting employees and contractors to verify whether 
any individual had been suspended or excluded or 
charged with a criminal offense relating to the provi-
sion of federal health care services. 
47 
We are not aware of any individuals employed in contra-
vention of the prohibitions in the CIA. 
Record Retention 
Our record retention policy is consistent with the require-
ments of the CIA. 
Signed by: 
Chief Executive Officer 
Chief Financial Officer 
Corporate Compliance Officer 
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APPENDIX C 
Sample Engagement Letter 
The following is an illustration of a sample engagement letter that may be 
used for this kind of engagement. 
[CPA Firm Letterhead] 
[Client's Name and Address] 
Dear : 
This will confirm our understanding of the arrangements for our perfor-
mance of certain agreed-upon procedures in connection with manage-
ment's compliance with the terms of the Corporate Integrity Agreement 
(CIA) with the Office of Inspector General (OIG) of the U.S. Department 
of Health and Human Services (HHS) dated [date of CIA] for the period 
ending [date]. 
We will perform those procedures enumerated in the attachment to this 
letter. Our responsibility is to carry out these procedures and report our 
findings. We will conduct our engagement in accordance with standards 
established by the American Institute of Certified Public Accountants. 
Our planned procedures were agreed to by management and will be com-
municated to the OIG for its review and are based on the terms specified 
in the CIA. The sufficiency of these procedures is solely the responsibility 
of the specified users of the report. Consequently, it is understood that we 
make no representation regarding the sufficiency of the procedures de-
scribed in the attachment for the purpose for which this report has been 
requested or for any other purpose. 
Management is responsible for the Company's compliance with all ap-
plicable laws, regulations, and contracts and agreements, including the 
CIA. Management also is responsible for the design, implementation, 
and monitoring of the policies and procedures upon which compliance 
is based. 
Our engagement to perform agreed-upon procedures is substantially less 
in scope than an examination, the objective of which is the expression of 
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an opinion on management's compliance with the CIA. Accordingly, we 
will not express such an opinion or any other form of assurance thereon.1 
Working papers that are prepared in connection with this engagement 
are the property of the independent accountant. The working papers 
are prepared for the purpose of providing the principal support for the 
independent accountant's report. At the completion of our work, we ex-
pect to issue an agreed-upon procedures report in the attached form. 
If, however, we are not able to complete all of the specified procedures, 
we will so advise you. At that time, we will discuss with you the form of 
communication, if any, that you desire for our findings. We will ask you 
to confirm your request in writing at that time. If you request that we 
delay issuance of our report until corrective action is taken that will re-
sult in compliance with all aspects of the CIA, we will do so only at your 
written request. Our working papers will be retained in accordance with 
our firm's working paper retention policy. 
The distribution of the independent accountant's report will be restricted 
to the governing board and management of the Company and the OIG. 
Our fees will be billed as work progresses and are based on the amount 
of time required at various levels of responsibility plus actual out-of-
pocket expenses. Invoices are payable upon presentation. We will notify 
you immediately of any circumstances we encounter that could signifi-
cantly affect our initial estimate of total fees. 
We agree that to the extent required by law, we will allow the Comptrol-
ler General of the United States, HHS, and their duly authorized repre-
sentatives to have access to this engagement letter and our documents 
and records to the extent necessary to verify the nature and amount of 
costs of the services provided to the Company, until the expiration of 
four years after we have concluded providing services to the Company 
that are performed pursuant to this Engagement Letter. In the event the 
Comptroller General, HHS, or their duly authorized representatives 
1. The independent accountant may wish to include an understanding with the client about 
any limitation or other arrangements regarding liability of the practitioner or the client in 
the engagement letter. For example, the following might be included in the letter: 
Our maximum liability relating to services rendered under this letter (regard-
less of form of action, whether in contract, negligence or otherwise) shall be lim-
ited to the charges paid to us for the portion of the services or work products 
giving rise to liability. We will not be liable for consequential or punitive dam-
ages (including lost profits or savings) even if aware of their possible existence. 
You will indemnify us against any damage or expense that may result from any 
third-party claim relating to our services or any use by you of any work product, 
and you will reimburse us for all expenses (including counsel fees) as incurred 
by us in connection with any such claim, except to the extent such claim (i) is 
finally determined to have resulted from our gross negligence or willful miscon-
duct or (ii) is covered by any of the preceding indemnities. 
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request such records, we agree to notify the Company of such request as 
soon as practicable. 
In the event we are requested or authorized by the Company or are re-
quired by government regulation, subpoena, or other legal process to pro-
duce our documents or our personnel as witnesses with respect to our 
engagements for the Company, the Company will, so long as we are not 
a party to the proceeding in which the information is sought, reimburse 
us for our professional time and expenses, as well as the fees and ex-
penses of our counsel, incurred in responding to such requests. 
If this letter correctly expresses your understanding of this engagement, 
please sign the enclosed copy where indicated and return it to us. We 
appreciate the opportunity to serve you. 
Sincerely, 
[Partner's Signature] 
[Firm Name or Firm Representative] 
Accepted and agreed to: 
[Client Representative's Signature] 
[Title] 
[Date] 
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APPENDIX D 
Sample Procedures 
Procedure Findings 
Governance 
1. We read the Company's corporate minutes 
and organization chart and ascertained 
that, within [number] days of the date of 
the Corporate Integrity Agreement (CIA), 
the Company— 
a. Established a Compliance Committee, 
which is to meet meets at least monthly 
and requires a quorum to meet. 
b. Appointed to its Compliance Commit-
tee members who include, at a mini-
mum, those individuals specified in 
the CIA. 
c. Delegated to the Compliance Commit-
tee the authority to implement and 
monitor the CIA, as evidenced by the 
organization chart or the Compliance 
Committee's charter. 
d. Appointed a compliance officer who 
reports directly to the individual spec-
ified in the CIA. 
2. We interviewed the compliance officer 
and were informed that, in his or her opin-
ion, the Compliance Officer— 
a. Has sufficient staff and resources to 
carry out his or her responsibilities. 
b. Actively participates in compliance 
training. 
c. Has the authority to conduct full and 
complete internal investigations with-
out restriction. 
d. Periodically revises the compliance 
program to meet changing circum-
stances and risks. 
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Procedure Findings 
3. We read the OIG notification letter as 
specified in the CIA and noted that the ap-
propriate official signed the letter, that it 
was addressed to the OIG, that it covered 
items (a) through (d) in Step 1, and that it 
was dated within [number of] days of the 
execution of the CIA. 
Billing Practices, Policies, 
and Procedures 
The practitioner might be engaged to pro-
vide consulting services in connection with 
the evaluation of the company's billing 
practices, policies, and procedures. If so, 
generally no agreed-upon procedures would 
be performed relating to this area. 
Alternatively, if the procedures relating to 
the Company's billing practices, policies, 
and procedures are performed by others 
such as the Company's internal audit staff, 
the practitioner performs Steps 4 through 9. 
4. We read the compliance work plan and 
noted the following. 
a. The work plan's stated objectives in-
clude the determination that billings 
are accurate and complete, for services 
rendered that have been deemed by 
medical specialists as being necessary, 
and are submitted in accordance with 
federal program guidelines. 
b. The work plan sampling methodology 
sets confidence levels consistent with 
those defined in the CIA. 
c. The work plan identifies risk areas, as 
defined in the CIA (if applicable), and 
specifies testing procedures by risk area. 
d. The work plan specifies that samples 
are taken in risk areas (if applicable) 
identified by the CIA. 
e. The work plan includes testing proce-
dures, which the practitioner should 
modify as required by the CIA, for the 
following risks areas (if applicable) 
identified in the CIA 
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Procedure Findings 
1) Clinical documentation, as follows: 
i) No documentation of service 
ii) Insufficient documentation of 
service 
iii) Improper diagnosis or treat-
ment plan giving rise to the 
provision of a medically un-
necessary service or treatment 
iv) Service or treatment does not 
conform medically with the 
documented diagnosis or treat-
ment plan 
v) Services incorrectly coded 
2) Billing and coding, as follows: 
i) Noncovered or unallowable 
service 
ii) Duplicate payment 
iii) DRG window error 
iv) Unbundling 
v) Utilization 
vi) Medicare credit balances 
[Note to Practitioner: Modify the preceding 
list as required by the CIA.] 
5. We selected [quantity] probe samples 
performed by the independent review or-
ganization for the following risk areas [list 
risk areas tested]. For the probe samples 
selected, we noted that the— 
a. Sample patient billing files were ran-
domly selected. 
b. Sample size reflected confidence levels 
specified in the CIA. 
c. Sample plan describes how missing 
items (if any) would be treated. 
d. Patient billing files tested were pulled 
per the listing of random numbers and 
all patient billing files were accounted 
for in the working papers. 
e. Work plans for the specific sample 
described the risk areas (if applicable) 
being tested and the testing approach/ 
procedures. 
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Procedure Findings 
f. Working papers noted the completion 
of each work plan step. 
g. Working papers contained a summary 
of findings for the sample 
6. We reperformed the work plan steps [list 
of specific steps performed] for the sample 
patient billing files. The reperformance of 
work plan steps related to the medical re-
view of the sample patient billing files was 
performed by the following individuals 
[note the professional qualifications of in-
dividuals without listing names]. Any ex-
ceptions between our findings and the 
Company's are summarized in the Attach-
ment to this report. 
7. We read the summary findings of all inter-
nal compliance reviews that the Com-
pany's Internal Audit department indicated 
it had performed for the Company and 
noted that all material billing deficiencies 
[ spec i fy material threshold as defined by 
the Company] noted therein were dis-
cussed in written communications ad-
dressed to the appropriate payor (for 
example, Medicare Part B carrier) and 
were dated within 60 days from the time 
the deficiency occurred.1 
8. We inquired of [individual] as to whether 
the Company took remedial steps within 
[number of] days (or such additional time 
as agreed to by the payor) to correct all 
material billing deficiencies noted in Step 
7. We were informed that such remedial 
steps had been taken. 
9. By reading applicable correspondence, we 
noted that any material billing deficien-
cies noted in Step 7 were communicated 
to the OIG, including specific findings rel-
ative to the deficiency, the Company's 
actions taken to correct the deficiency, 
1. The CIA provides it own legal definition of a "material deficiency." Determination of 
whether a billing or other act meets this definition is normally beyond the auditor's 
professional competence and may have to await final determination by a court of law. 
Accordingly, to avoid confusion, a working definition different from that provided in the 
CIA (e.g., a specified dollar threshold) may be necessary. 
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Procedure Findings 
and any further steps the Company plans 
to take to prevent any similar deficien-
cies from recurring. 
Corporate Integrity Policy 
10. We read the Company's Corporate Integrity 
Policy and noted the following. 
a. The policy was developed and imple-
mented within [number of] days of ex-
ecution of the CIA. 
b. The policy addressed the Company's 
commitment to preparation and sub-
mission of accurate billings consistent 
with the standards set forth in federal 
health care program statutes, regula-
tions, procedures, and guidelines or as 
otherwise communicated by HCFA, its 
agents, or any other agency engaged in 
the administration of the applicable 
federal health care program. 
c. The policy addressed the specific issues 
that gave rise to the settlement, as well 
as other risk areas identified by the 
OIG in published Fraud Alerts issued 
through [agency]. 
d. Correspondence addressed to the OIG 
covered the development and imple-
mentation of the policy. 
e. Documentation indicating that the pol-
icy was distributed to all employees, 
physicians, and independent contrac-
tors involved in submitting or prepar-
ing requests for reimbursement. 
f. The prominent display of a copy of the 
policy on the Company's premises. 
11. We selected a sample of ten employees 
(involved in submitting and preparing re-
quests for reimbursement) and examined 
written confirmation in the employee's 
personnel file indicating receipt of a copy 
of the Corporate Integrity Policy. 
Information and Education Program 
12. We read the Company's Information and 
Education Program and noted the following. 
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a. The Information and Education Pro-
gram agenda was dated within [number 
of] days of execution of the CIA. 
b. Correspondence covering the devel-
opment and implementation of the In-
formation and Education Program was 
addressed to the OIG. 
c. The Information and Education Pro-
gram requires that each officer, em-
ployee, agent, and contractor charged 
with administering federal health care 
programs (including, but not limited 
to billers, coders, nurses, physicians, 
medical records, hospital administra-
tion and other individuals directly in-
volved in billing federal health care 
programs) receive at least [number of] 
hours of training. 
13. We selected a sample of ten employees 
involved in billing, coding and/or charge 
capture and examined sign-in logs of the 
training classes and noted that each had 
signed indicating that they had received 
at least [number of] hours of training as 
specified in the Information and Education 
Program. We also reviewed tests and sur-
veys completed by each of the ten trained 
employees noting evidence that they 
were completed. 
14. We inquired as to the training of individ-
uals not present during the regularly sched-
uled training programs and were informed 
that each such individual is trained either 
individually or in a separate make-up ses-
sion. We inquired as to the names of indi-
viduals not initially present and selected 
one such individual and examined that 
individual's post-training test and survey 
for completion. 
15. We read the course agenda and noted that 
the training provided to employees in-
volved in billing, coding, and/or charge 
capture consisted of instructions on sub-
mitting accurate bills, the personal oblig-
ations of each individual to ensure billings 
are accurate, the nature of company-
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imposed disciplinary actions on individu-
als who violate company policies and/or 
laws and regulations applicable to federal 
health care program rules, legal sanctions 
against the company for submission of 
false or fraudulent information, and how 
to report potential abuses or fraud. We 
also noted that the training material ad-
dressed the following issues which gave 
rise to the settlement [practitioner list]. 
16. We inquired of the Corporate Compliance 
Officer as to the qualifications and experi-
ence of the trainers and were informed 
that, in the Corporate Compliance Offi-
cer's opinion, they were consistent with 
the topics presented. 
17. We noted that the Company's draft Annual 
Report to the OIG dated [date] addresses 
certification of training. 
Confidential Disclosure Program 
18. We read documentation of the Company's 
Confidential Disclosure Program and noted 
that it— 
a. Includes the printed effective date 
that was within [number of] days of 
execution of the CIA. 
b. Consists of a confidential disclosure 
program enabling any employee to 
disclose any practices or billing proce-
dures relating to federal health care 
programs. 
c. Provides a toll-free telephone line main-
tained by the Company, which Com-
pany representatives have indicated is 
maintained twenty-four hours a day, 
seven days a week, for the purpose of 
making any disclosures regarding com-
pliance with the Company's Compli-
ance Program, the obligations in the 
CIA, and Company's overall compli-
ance with federal and state standards. 
d. Includes policies requiring the review 
of any disclosures to permit a determi-
nation of the appropriateness of the 58 
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billing practice alleged to be involved 
and any corrective action to be taken 
to ensure that proper follow-up is con-
ducted. 
19. We made five test calls to the toll free 
telephone line (hotline) and noted the 
following. 
a. Each call was captured in the hotline 
logs and reported with all other in-
coming calls. 
b. Anonymity is not discouraged. 
20. We noted that the Company included in 
its draft Annual Report addressed to OIG 
dated [date] a detailed summary of the 
communications (including the number 
of disclosures by employees and the dates 
of such disclosures) concerning billing 
practices reported as, and found to be, 
inappropriate under the Confidential Dis-
closure Program, and the results of any 
internal review and the follow-up on such 
disclosures. 
21. We observed the display of the Company's 
Confidential Disclosure Program, includ-
ing notice of the availability of its hotline, 
on the Company's premises. 
Excluded Individuals or Entities 
22. We read the Company's written policy re-
lating to dealing with excluded or con-
victed persons or entities and noted that 
the policy— 
a. Prohibits the hiring of or contracting 
with an individual or entity that is 
listed by a federal agency as convicted 
of abuse or excluded, suspended, or 
otherwise ineligible for participation 
in federal health care programs. 
b. Includes a process to make an inquiry 
into the status of any potential em-
ployee or independent contractor. 
c. Provides for a semi-annual review of 
the status of all existing employees and 
contractors to verify whether any indi-
vidual had been suspended or excluded 
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or charged with a criminal offense relat-
ing to the provision of federal health 
care services. 
23. We selected a sample of ten employees 
hired over the course of the test period as 
defined in the CIA and examined support 
in the employee's personnel file docu-
menting inquiries made into the status of 
the employee, including documentation 
of comparison to the [source specified in 
the CIA]. 
24. We performed the following procedures 
related to the Company's semi-annual 
review of employee status. 
a. Read documentation of the semi-an-
nual review as evidence that a review 
was performed. 
b. Selected and reviewed the lesser of 
ten or all exceptions and determined 
that such employees were removed 
from responsibility for or involve-
ment with Provider business opera-
tions related to the Federal health 
care programs. 
c. Examined a notification letter ad-
dressed to the OIG and dated within 
30 days of the employee's removal 
from employment. 
d. Inquired of [officer] as to whether he 
or she was aware of any individuals 
employed in contravention of the pro-
hibitions in the CIA. If so, we further 
noted that [indicate specific proce-
dures] to confirm that such situation 
was cured within 30 days by [indicate 
how situation was cured]. 
Annual Report 
25. We read the Company's draft Annual Re-
port dated [date] and determined that it 
included the following items, to be modi-
fied as appropriate, by the practitioner: 
a. Compliance Program Charter and orga-
nization chart 
b. Amendments to policies 
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c. Detailed descriptions of reviews and 
audits 
d. Summary of hotline communications 
e. Summary of annual review of employees 
f. Cross-referencing to items noted in 
the CIA 
Record Retention 
26. We read the Company's record retention 
policy and noted that it was consistent with 
the requirements as outlined in the CIA. 
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Sample Report 
Independent Accountant's Report 
[Date] 
Sample Health Care Provider 
Office of Inspector General of the 
U.S. Department of Health and Human Services 
We have performed the procedures enumerated in the Attachment, 
which were agreed to by Sample Health Care Provider (Company) and 
the Office of Inspector General (OIG) of the U.S. Department of Health 
and Human Services, solely to assist the users in evaluating manage-
ment's assertion about [name of entity's] compliance with the Corporate 
Integrity Agreement (CIA) with the OIG dated [date of CIA] for the 
[period] ending [date], which is included as Attachment A to this report. 
This agreed-upon procedures engagement was performed in accordance 
with standards established by the American Institute of Certified Public 
Accountants. The sufficiency of these procedures is solely the responsi-
bility of the specified users of the report. Consequently, we make no rep-
resentation regarding the sufficiency of the procedures described in 
Attachment B either for the purpose for which this report has been 
requested or for any other purpose. 
We were not engaged to and did not perform an examination, the objec-
tive of which would be the expression of an opinion on management's 
compliance with the CIA. Accordingly, we do not express such an opin-
ion. Had we performed additional procedures, other matters might have 
come to our attention that would have been reported to you. 
This report is intended solely for the information and use of the Compli-
ance Committee and management of the Company and the OIG, and is 
not intended to be and should not be used by anyone other than those 
specified parties. 
Include as Attachments the CIA and the summary that enumerates 
procedures and findings. 
[Signature] 
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